Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Forrester

Teva facing $2bn liability for at-risk generic Protonix launch

Potential litigation costs from Pfizer are triple the generics firm's original estimates

- PMLiVE

Technology trends facing pharma in 2013

Context-based services and social media are among the major technology trends pharma will need to embrace in 2013

- PMLiVE

Building brand strength – Part 4

Commitment, responsiveness and protection – how far will Big Pharma go to preserve its brands?

Why digital healthcare means strategy is now vital

Thought Leader: Going digital means that the process of proper planning of both messages and campaigns is once again useful in healthcare

- PMLiVE

Publicis merges Digitas and LBi competencies to form leading global network

Publicis Groupe to combine digital strengths by forming DigitasLBi

Digital reach is ‘gold dust’ for pharma

How companies perform online will be a key differentiating factor, says Merck & Co's Gerhard Arnhofer

- PMLiVE

FDA proffers guidance for new Alzheimer’s drugs

Encourages approach that tackles disease in its early stages

- PMLiVE

Sanofi launches voice-guided epinephrine auto-injector in US

Auvi-Q extends pharma company's interests in innovative devices

- PMLiVE

Pfizer UK transfers online male health clinic to charity

Hands over Man MOT initiative to the Men's Health Forum

- PMLiVE

Strong start for Pfizer spin-out Zoetis

Animal health unit makes stock market debut

- PMLiVE

NICE turns down diabetes and ovarian cancer drugs for NHS use

Disappointment for BMS/AZ’s Forxiga and Roche’s Avastin

- PMLiVE

Pfizer revenues decline in Q4 but profits surge

Lipitor patent loss continues to hit sales

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links